Table 1.

Increases of mean fluorescence intensity reflecting surface expression level of αIIbβ3 and CD42b by K562 cells after treatment by PHA/PMA/act D- or PHA/act D-generated MVs



PHA + PMA + act D

PHA + act D

βIIbβ3
CD42b
αIIbβ3
CD42b
Control cells   53.3 ± 4.6   63.4 ± 8.9   33.2 ± 1.7   55.7 ± 9.6  
MV     
    1 μg/mL   403.8 ± 40.2*  81.4 ± 26.7   ND   ND  
    5 μg/mL   493.3 ± 58.3  113.6 ± 9.2*  56.7 ± 7.8   78.9 ± 22.3  
    10 μg/mL
 
680.2 ± 62.5
 
286.7 ± 45.2*
 
78.9 ± 8.4*
 
106.4 ± 22.9*
 


PHA + PMA + act D

PHA + act D

βIIbβ3
CD42b
αIIbβ3
CD42b
Control cells   53.3 ± 4.6   63.4 ± 8.9   33.2 ± 1.7   55.7 ± 9.6  
MV     
    1 μg/mL   403.8 ± 40.2*  81.4 ± 26.7   ND   ND  
    5 μg/mL   493.3 ± 58.3  113.6 ± 9.2*  56.7 ± 7.8   78.9 ± 22.3  
    10 μg/mL
 
680.2 ± 62.5
 
286.7 ± 45.2*
 
78.9 ± 8.4*
 
106.4 ± 22.9*
 

Results are expressed as ± SEM. Data are from 8 experiments.

ND indicates not determined.

*

P < .05 significantly different from control cells.

P < .01, significantly different from control cells.

Close Modal

or Create an Account

Close Modal
Close Modal